Skip to main content
CDC Website

Treatment Guidelines Materials

MMWR: Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations--United States, 2001

This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.

Lantos-Hyde US Government Tuberculosis Strategy

In response to the urgent need to control the spread of TB, the U.S. Congress passed the Reauthorization Act supporting a substantial increase in USG funding for TB treatment and control over a five-year period. The Reauthorization Act requests the development of a USG Global Tuberculosis Strategy.

Smoking Cessation and Smokefree Environments for Tuberculosis Patients

This Guide describes how to make TB services 100% tobacco-free, then presents ‘ABC for TB’, an intervention for TB programmes to help patients quit smoking and to promote smokefree homes for patients and families. It advocates keeping cessation simple, expanding it widely through the health services and reaching communities. ‘ABC for TB’ does not require specialised staff, clinics or medicines. It is delivered systematically within routine programme activities and can be done within as little as 2-5 minutes. It includes recording and monitoring processes and outcomes.